Seller review · medication price and fees
Maves, priced
Maves separates first-month discounts from later program prices. Bundles are different purchases, and the mixed legal document leaves testing charges and the governing membership terms unresolved.
By Derek Moss, pricing analyst · Updated October 2026
Semaglutide injection
$249/moKnown subtotal $249 a month, Extra fees unconfirmed.
Itemized bill
Maves
Semaglutide injection
Totals are our arithmetic from the seller’s published figures. Extra fees unconfirmed: the seller states no amount for separate access charge or diagnostic assessment or quest testing. Known subtotals exclude these charges; the final bill may be higher.
The bill, in one line
Use the ordinary product price when planning ongoing costs. Clarify the older billing provisions before assuming every assessment or test is included.
Maves sells individual compounded treatments and combined protocols. Keeva provides clinical care, while Homera Health operates the platform. A bundle quote cannot price each ingredient separately. The older billing agreement also contains other platform references.
The semaglutide price is $189 initially, then $249 per month. For tirzepatide, it is $249 initially, then $349. Similarly, sermorelin is $149 initially, then $199. NAD is $169 initially, then $229. The headline differs from the ordinary price because it reflects a first-month promotion. Additional assessment and testing liability still needs clarification.
Every price, in the seller’s own unit
A per-vial price stays per vial. A calendar-month figure appears only where the seller’s unit carries one, and a cost per milligram only where the seller states how much the unit holds. Where the seller bills by the four-week fill or the package, or leaves a required fee outside its price, the calendar-month figure is our arithmetic and is marked as ours.
| Product | Seller’s price | Per calendar month | Per mg | Read |
|---|---|---|---|---|
| NAD+, injection | $229/mo | $229/mo | — | October 2026 |
| Semaglutide, injection | $249/mo | $249/mo | — | October 2026 |
| Sermorelin, injection | $199/mo | $199/mo | — | October 2026 |
| Tirzepatide, injection | $349/mo | $349/mo | — | October 2026 |
Lowest monthly, by form: Injection From $199/mo (Sermorelin)
Fees outside the headline
Separate access chargenot published
Mixed legal-platform references leave the selected program’s additional access charge unresolved.
Read October 2026
Diagnostic assessmentnot published
The agreement separates a diagnostic visit, but its current application and charge need confirmation.
Read October 2026
Quest testingnot published
The agreement describes outside laboratory liability without a universal current price.
Read October 2026
Advertised standard deliveryincluded
Current treatment marketing includes shipping; confirm the selected program.
Read October 2026
See Maves’s current price
Semaglutide injection at $249/mo.Prices move; check the seller’s own page before you pay.
The fine print
- Prepay
- The homepage’s GLP-1 and sermorelin bundle starts at $248, then $348 per month. Adding NAD produces a separate $299 introductory and $399 later bundle. These are combined offers, not discounts automatically available on individual prescriptions. Confirm the exact payment and shipment schedule.
- Cancellation
- The older January 2022 general agreement describes recurring membership approximately every 28–30 days and calls paid membership nonrefundable. It lists account, telephone and email cancellation routes. Confirm which older billing provisions apply to the current product. The August 2026 consent separately identifies Keeva clinical care and Homera platform support. Obtain the applicable notice deadline and pharmacy refund cutoff before paying.
- Shipping
- Current marketing promotes free shipping. Confirm the selected product and destination. The legal text separately discusses diagnostic and laboratory charges. A delivery inclusion does not resolve those costs. Ask for the actual pharmacy and replacement terms before ordering.
Worth it, and what to watch
Worth it
- Ordinary product prices published
- Promotional periods distinguished
- Bundles identified separately
- Delivery inclusion advertised
Watch for
- Initial price understates later cost
- Legacy payment provisions require confirmation
- Outside testing can add cost
- Refund and renewal details need confirmation
- Buy here if
- A buyer comparing ordinary individual rates with the full cost of a selected bundle.
- Look elsewhere if
- A buyer treating the first-month offer as the regular price or mixing different bundle components.
Price it elsewhere
Other sellers that publish a semaglutide injection price. Sellers we have reviewed come first, then sellers we have only priced; each group runs lowest price first.
FAQ
2 questionsIs the first-month price the ordinary rate?
No. Each product page separately lists a higher amount for later months.
Can the combined protocol price be assigned to each ingredient?
No. The combined purchase has its own terms and cannot establish standalone ingredient prices.
Price it at Maves
Every figure above was read from Maves’s own pages. The current one is a click away.
Before you buy
- What a sermorelin prescription costs, all-in
- NAD+ injection vs IV vs nasal spray: how each is priced
- What "compounded" means for a peptide's price, and why some can't be prescribed
- What compounded tirzepatide costs a month, all-in
- What compounded semaglutide costs a month, all-in
- Why one seller quotes four different prices for the same peptide
Questions the research answers
Other sellers we have priced
| Collective | $76/mo |
|---|---|
| Avono Health | $79/mo |
| Lean Meds | $79/mo |
| RxPepsDirect | $79/mo |
| Mondae | $87/mo |
| Enhanced | $89/mo |
| Sunlight | $88 per 4 wks ($95.33/mo, our calendar-month conversion) |
| CoreAge Rx | $99/mo |
Where every figure comes from
- Semaglutide introductory and ordinary program prices
- Tirzepatide preparation and ordinary price
- Sermorelin administration and claims
- NAD injection and program price
- Membership, testing liability and clinical-entity references
- Bundle prices and platform claims
- Current Keeva clinical agreement and platform relationship